Table of Contents
Imagine sitting in the middle of an important office meeting, cheering on the sidelines of your child's soccer game, or enjoying a quiet romantic dinner, when suddenly, you feel a warm drip. Your nose has started gushing blood. Panic sets in. You grab whatever crumpled tissue, rough paper towel, or fast-food napkin you can find, frantically pinching your nose and hoping the bleeding stops before you ruin your clothes. It is a messy, embarrassing, and incredibly inconvenient experience that millions of Americans face every single year.
For decades, we have treated cuts and scrapes on our skin with simple, reliable adhesive bandages. But when it came to nosebleeds, we were stuck in the dark ages of first aid. That was the reality until a clever, highly effective little product called Nampons made its way into the spotlight.
Promising to treat a bloody nose as easily as you treat a scraped knee, Nampons stepped onto the Shark Tank stage in Season 17. The founder walked in with incredible sales data, a smart medical product, and a sky-high valuation. What followed was a tense negotiation, a deep dive into company profits, and a massive deal that would completely change the trajectory of the business.
What is Nampons?
Nampons is a brand of over-the-counter nasal tampons specifically engineered to stop nosebleeds quickly, cleanly, and safely. If you get frequent nosebleeds from dry indoor heat, seasonal allergies, or minor sports bumps, you know that rolling up a bathroom tissue and stuffing it up your nose rarely works well. Tissues become soggy, lose their shape, and often leave behind a sticky, bloody mess.
Nampons are entirely different. They are small, single-use, medical-grade plugs designed to fit comfortably inside the nostril without sticking out awkwardly. Once inserted, the soft material gently expands to absorb the blood. This expansion applies a very light, even pressure to the fragile blood vessels right inside the front of your nose, which is where the vast majority of common nosebleeds start.
But the real magic is in the chemistry. Nampons contain a proprietary, clinically proven active ingredient called micro-dispersed oxidized cellulose. This is a powerful, safe, and widely used medical clotting agent. It provides a physical structure for your blood platelets to collect and stabilize. Because of this targeted pressure and advanced clotting technology, Nampons stop bleeding up to twice as fast as simply pinching your nose. They are highly discreet, easy to carry in a purse, backpack, or first-aid kit, and completely painless to remove once the bleeding has stopped.
| Feature | Product Overview Details |
|---|---|
| Company Name | Nampons |
| Founded Year | 2021 |
| Core Product | Medical-grade nosebleed stoppers |
| Active Ingredient | Micro-dispersed oxidized cellulose |
| Target Audience | Kids, adults, seniors, and athletes |
| Retail Price | Approx. $12.99 - $19.99 (depending on pack size) |
Who is the Founder of Nampons?
The brain behind the brand is Joshua Lippiner, a highly driven serial entrepreneur and a 1998 graduate of Lehigh University. Lippiner was not a medical doctor, but he had a sharp eye for identifying everyday problems that lacked simple solutions.
Right out of college, he jumped headfirst into the dot-com boom, eventually co-founding an online market research business that he successfully grew and sold. Over the next two decades, he launched a string of different ventures, ranging from an online travel platform to a wholesale agricultural network.
The idea for Nampons came from a very simple realization: the current way people dealt with nosebleeds was terrible. "It can happen to a four-year-old as easily as a 70-year-old," Lippiner noted. "Not having the right product out there for nosebleeds is crazy in retrospect."
He knew he wanted to create something small, highly absorbent, and medically safe. During his intensive research and development phase, he stumbled upon a medical project that an Oregon-based company had acquired back in 2013. The project was brilliant, but it was just sitting there, gathering dust. The company had done absolutely nothing with it. Lippiner immediately recognized this dormant technology as the exact missing piece he needed.
After his initial emails to the company's sales manager went completely ignored, Lippiner changed his strategy. He found the company's CEO on LinkedIn and sent a direct message. The CEO replied almost immediately, asking, "Did you go to Lehigh?" It turned out the CEO was a proud parent of a current Lehigh student. That shared collegiate connection sparked a warm conversation, which quickly turned into a friendship, and eventually, a formal business deal to acquire the technology.
In 2021, Lippiner officially launched his first trial run of Nampons. He ordered 1,500 units, believing that supply would comfortably last him about three months. Instead, the demand was so overwhelming that he sold out of his entire stock in just three weeks.
Nampons Shark Tank Journey & Pitch
With incredible early traction under his belt, Lippiner knew he needed a strategic partner to take Nampons to the next level. After applying to Shark Tank, his team heard back in just one week. He navigated the rigorous interview rounds and soon found himself walking down the famous hallway to face the Sharks in Season 17, Episode 8.
Lippiner walked onto the carpet seeking $350,000 in exchange for 5% equity in his company. This initial ask placed a massive $7 million valuation on the nosebleed business, immediately raising the Sharks' eyebrows.
He wasted no time backing up his high valuation with hard numbers. The Sharks were incredibly impressed when Lippiner revealed that Nampons had generated an impressive $3.4 million in sales the previous year and was actively projecting $3.8 million for the current year. Even better, he had already cracked the code of big-box retail, successfully landing the product on the shelves of 1,200 Walmart locations across the country.
However, the mood in the room shifted when the Sharks dug into the bottom line. Despite the multi-million dollar revenue, the company's net profit had recently plummeted from $800,000 down to just $200,000. Lippiner explained that this drop was entirely due to aggressive reinvestment into the business, spending heavy cash on marketing, expanding inventory, and securing those massive retail slots.
The Sharks were hesitant. A $7 million valuation based on $200,000 in net profit equaled a massive 35x earnings multiple, which most investors consider far too aggressive for an over-the-counter consumer good. Furthermore, some Sharks worried about the defensibility of the product, questioning what would stop a medical giant like Johnson & Johnson from creating a copycat version.
| Element | Pitch & Offers Details |
|---|---|
| Season / Episode | Season 17, Episode 8 |
| Initial Ask | $350,000 for 5% equity |
| Initial Valuation | $7,000,000 |
| Sharks in the Room | Mark Cuban, Lori Greiner, Kevin O'Leary, Robert Herjavec, Michael Strahan (Guest) |
| Offers Made | Robert & Michael: $350,000 for 10% equity + $0.10 royalty per unit until recouped |
| Final Deal Accepted | $350,000 for 10% equity + $0.10 royalty per unit until recouped (Robert & Michael) |
Sensing the blood in the water, Lippiner stood his ground, defending his sales data and his strategic advisory board of hematologists and Ear, Nose, and Throat (ENT) doctors. His sharp defense caught the eye of two specific investors: veteran tech mogul Robert Herjavec and guest Shark, NFL Hall of Famer Michael Strahan.
Strahan loved the product's potential for the massive sports market, while Herjavec saw the clear retail path. Together, they formed a powerful duo and threw out an offer. They would give Lippiner the $350,000 he needed, but they demanded 10% equity (double what he offered), plus a $0.10 royalty on every single unit sold until they recouped their entire $350,000 investment.
After a brief negotiation, Lippiner knew the value of having an NFL superstar and a seasoned business veteran on his team. He happily accepted the deal.
What Happened to Nampons After Shark Tank?
Any entrepreneur will tell you that the "Shark Tank effect" is very real, but for Nampons, it was practically a tidal wave. When you pitch a product that solves a highly relatable, everyday medical problem to millions of viewers on a Friday night, the public response is going to be explosive.
"With their endorsement and support, we've seen sales quadruple and quintuple," Lippiner reported shortly after the episode aired. "We had six months of inventory, and within 24 hours of the episode airing, we nearly sold out."
The immediate cash injection and strategic guidance from Herjavec and Strahan allowed Nampons to stabilize their supply chain quickly. They ramped up their manufacturing capabilities to ensure they never ran out of stock during major retail pushes.
Furthermore, Michael Strahan's deep connections in the professional sports world gave Nampons a serious edge. Nosebleeds are incredibly common in contact sports, from youth soccer and high school wrestling to professional football and mixed martial arts. Having a sports legend backing the brand gave them instant credibility in locker rooms across America.
Is Nampons Still in Business?
Yes, as of 2026, Nampons is not only still in business but absolutely thriving. The company has vastly expanded its footprint and solidified its position as a staple in household medicine cabinets.
They currently offer several variations of their core product. The standard Nampons for Nosebleeds remains their flagship item, but they have also seen massive success with Nampons Kids Nosebleed Stoppers, which have become the #1 recommended brand by many pediatricians. Because children are so prone to nosebleeds, often due to dry air or simply picking their noses, parents have flocked to the brand. Nampons also sells an Emergency Nosebleed Kit, which bundles everything a family needs into one convenient travel package.
Looking toward the future, the company is actively preparing to launch Nampons Sport, a specialized version of the product explicitly designed to handle the heavy, sudden bleeds that occur on the field or the court.
The brand has also garnered significant press coverage. High-profile medical professionals, like Dr. Tonia Farmer, frequently recommend Nampons on local news segments as a must-have item for every family's summer safety and back-to-school first-aid kit.
What is the Valuation & Net Worth of Nampons?
Valuations in the private sector can be tricky to pin down, but we can make highly educated estimates based on the company's verified financial data.
During the Shark Tank pitch, Lippiner's final accepted deal of $350,000 for 10% equity officially placed the company's baseline valuation at $3.5 million. However, that valuation was based on their pre-show numbers.
As of today, Nampons has officially sold over 3 million units across its lifetime. Given that the company was already tracking toward $3.8 million in annual revenue before the show, and sales "quintupled" during the immediate post-show boom, their annual revenue base is comfortably estimated to be well over the $5 million to $8 million mark today.
Because they have stabilized their reinvestment costs, optimized their manufacturing, and expanded their permanent retail footprint in major chains like Walmart, their profit margins have likely improved significantly.
Today, conservative business estimates place the overall valuation of Nampons somewhere between $10 million and $15 million. As the primary founder and majority shareholder, Joshua Lippiner's estimated net worth tied to the business is firmly in the multi-million dollar range.
Where to Buy Nampons?
Finding Nampons today is incredibly easy, a testament to their successful retail expansion strategy. For the absolute best bulk pricing, multi-packs, and direct customer support, buyers can purchase right from the official Nampons website.
For those who rely on fast shipping, Nampons maintains a massive presence on Amazon, where they frequently top the charts in first-aid categories. If you need them in an absolute emergency, you can walk into over 1,200 Walmart locations nationwide, as well as select local pharmacies, to pick up a box right off the shelf in the health and first-aid aisles.
Nampons Alternatives: What Else is Out There?
While Nampons dominates the modern, specialized nosebleed market, there are a few older alternatives people still use.
- Tissues and Cotton Balls: The classic, messy approach. These offer zero active clotting agents and often tear apart inside the nostril, leaving behind fibers that can trigger a secondary bleed when removed.
- Oxymetazoline Nasal Sprays (Afrin): Many people spray a decongestant like Afrin onto a cotton ball and place it in the nose, as the medication naturally constricts blood vessels. While effective, it requires buying two separate products and assembling it yourself while bleeding.
- BleedCease: This is a direct competitor that also uses a natural clotting agent. However, many users find the physical shape and comfort of Nampons superior for the actual nostril fit.
Are Nampons Reviews Good?
The customer feedback for Nampons is overwhelmingly positive. Across Amazon and the company's direct website, they boast thousands of five-star ratings.
Parents, in particular, are the most vocal supporters. Reviewers constantly highlight how the product takes the fear and panic out of childhood nosebleeds. Instead of crying over a blood-soaked towel, kids simply have a soft Nampon inserted, and within minutes, they are back to playing.
Adult users who suffer from chronic dry-air bleeds praise the product for its discretion; they can easily hide a small pack in a pocket or purse for emergencies. Ultimately, the consensus is clear: Nampons delivers exactly what it promises, turning a stressful medical mess into a quick, easy fix.
